» Articles » PMID: 35532937

Comparison of Survival Among Adults With Rectal Cancer Who Have Undergone Laparoscopic Vs Open Surgery: A Meta-analysis

Overview
Journal JAMA Netw Open
Specialty General Medicine
Date 2022 May 9
PMID 35532937
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Two large randomized clinical trials (RCTs) found that laparoscopic surgery failed to yield noninferior pathologic outcomes compared with open surgery for patients with rectal cancer. The results raised concerns regarding the effectiveness of the laparoscopic approach for patients with rectal cancer.

Objective: To compare the long-term oncologic outcomes of laparoscopic and open surgery for patients with rectal cancer.

Data Sources: PubMed, Web of Science, Embase, and Cochrane Central Register of Controlled Trials were searched from database inception to August 13, 2021. Studies published in English were retrieved.

Study Selection: The meta-analysis included RCTs that compared laparoscopic surgery with open surgery for patients with rectal cancer and reported the outcome of disease-free survival (DFS) or overall survival (OS). The following exclusion criteria were used: (1) non-RCTs, (2) studies without long-term survival outcomes of interest, and (3) studies that did not report Kaplan-Meier survival curves.

Data Extraction And Synthesis: This meta-analysis was performed in line with the Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guideline for individual participant data development groups. Individual participant data on DFS and OS were extracted from the published Kaplan-Meier survival curves. One-stage and 2-stage meta-analyses were performed.

Main Outcomes And Measures: Meta-analyses were conducted for DFS and OS. Hazard ratios (HRs) were used as effective measures.

Results: Of 8471 records screened, 10 articles with 12 RCTs and 3709 participants were selected. The reconstructed survival curves for the combined population showed that the 5-year estimated DFS rates were 72.2% (95% CI, 69.4%-74.8%) for the laparoscopic group and 70.1% (95% CI, 67.0%-73.0%) for the open surgery group, and the 5-year estimated OS rates were 76.2% (95% CI, 73.8%-78.5%) for the laparoscopic group and 72.7% (95% CI, 69.8%-75.3%) for open surgery group. In 1-stage meta-analyses, DFS had a nonsignificant HR of 0.92 (95% CI, 0.80-1.06; P = .26), which suggested that DFS in the laparoscopic and open surgery groups was comparable; however, OS was significantly better in the laparoscopic group (HR, 0.85; 95% CI, 0.74-0.97; P = .02). The results were confirmed by 2-stage meta-analyses and were validated by sensitivity analysis with large RCTs.

Conclusions And Relevance: A similar DFS but significantly better OS were found for patients who have undergone laparoscopic surgery compared with open surgery for rectal cancer. These findings address concerns regarding the effectiveness of laparoscopic surgery and support the routine use of laparoscopic surgery for patients with rectal cancer.

Citing Articles

Current and future perspectives in the management and treatment of colorectal cancer.

Romero-Zoghbi S, Krumina E, Lopez-Campos F, Counago F World J Clin Oncol. 2025; 16(2):100807.

PMID: 39995555 PMC: 11686563. DOI: 10.5306/wjco.v16.i2.100807.


Short-term and long-term outcomes of laparoscopic surgery for locally recurrent rectal cancer: a propensity score-matched cohort study.

Zhang J, Huang F, Niu R, Mei S, Quan J, Hu G Tech Coloproctol. 2024; 28(1):100.

PMID: 39138721 DOI: 10.1007/s10151-024-02977-5.


Current guidelines for the management of rectal cancer patients: a review of recent advances and strategies.

Martinez C, Campos F Rev Assoc Med Bras (1992). 2024; 70(suppl 1):e2024S112.

PMID: 38865532 PMC: 11164279. DOI: 10.1590/1806-9282.2024S112.


Laparoscopic versus open gastrectomy for nonmetastatic T4a gastric cancer: a meta-analysis of reconstructed individual participant data from propensity score-matched studies.

Pang H, Yan M, Zhao Z, Chen L, Chen X, Chen Z World J Surg Oncol. 2024; 22(1):143.

PMID: 38812025 PMC: 11134691. DOI: 10.1186/s12957-024-03422-5.


Development and validation of a competitive risk model in patients with rectal cancer: based on SEER database.

Hu R, Li X, Zhou X, Ding S Eur J Med Res. 2023; 28(1):362.

PMID: 37735712 PMC: 10515244. DOI: 10.1186/s40001-023-01357-3.


References
1.
Stevenson A, Solomon M, Brown C, Lumley J, Hewett P, Clouston A . Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial. Ann Surg. 2018; 269(4):596-602. DOI: 10.1097/SLA.0000000000003021. View

2.
Creavin B, Kelly M, Ryan E, Winter D . Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer. Br J Surg. 2017; 104(12):1609-1619. DOI: 10.1002/bjs.10664. View

3.
Kang S, Park J, Jeong S, Nam B, Choi H, Kim D . Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010; 11(7):637-45. DOI: 10.1016/S1470-2045(10)70131-5. View

4.
Lee G, Bordeianou L, Francone T, Blaszkowsky L, Goldstone R, Ricciardi R . Superior pathologic and clinical outcomes after minimally invasive rectal cancer resection, compared to open resection. Surg Endosc. 2019; 34(8):3435-3448. DOI: 10.1007/s00464-019-07120-2. View

5.
Biagi J, Raphael M, Mackillop W, Kong W, King W, Booth C . Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011; 305(22):2335-42. DOI: 10.1001/jama.2011.749. View